Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Abstract 4714: Elucidating mechanisms of acquired resistance to mobocertinib in non-small cell lung cancer harboring EGFR exon 20 insertion mutations

Gaku Yamamoto, Yu Tanaka, Yoshitaka Zenke, Jie Liu, Tetsuya Sakai, Hiroki Izumi, Eri Sugiyama, Shigeki Umemura, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto, Susumu S. Kobayashi, Hibiki Udagawa

Cancer Res (2025) 85 (8_Supplement_1): 4714.

https://doi.org/10.1158/1538-7445.AM2025-4714

Published: 21 April 2025

View articletitled, Abstract 4714: Elucidating mechanisms of acquired resistance to mobocertinib in non-small cell lung cancer harboring EGFR exon 20 insertion mutations

Journal Articles

Abstract 7198: Preclinical efficacy of the combination of MEK inhibitor plus KRAS G12D inhibitor for non-small cell lung cancer with KRAS G12D

Yu Tanaka, Mirai Tsukuda, Gaku Yamamoto, Eri Sugiyama, Hiroki Izumi, Tetsuya Sakai, Shigeki Umemura, Yoshitaka Zenke, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto, Hibiki Udagawa

Cancer Res (2025) 85 (8_Supplement_1): 7198.

https://doi.org/10.1158/1538-7445.AM2025-7198

Published: 21 April 2025

View articletitled, Abstract 7198: Preclinical efficacy of the combination of MEK inhibitor plus KRAS G12D inhibitor for non-small cell lung cancer with KRAS G12D

Journal Articles

Abstract 1026: A novel detection system of circulating tumor cells based on size-dependent enrichment with immunofluorescent staining of CK8/18 in advanced non-small cell lung cancer

Tetsuya Sakai, Yoshitaka Zenke, Mami Onishi, Eri Morita, Masatoshi Yanagida, Yuji Shibata, Hiroki Izumi, Kaname Nosaki, Hibiki Udagawa, Shingo Matsumoto, Kiyotaka Yoh, Koichi Goto

Cancer Res (2023) 83 (7_Supplement): 1026.

https://doi.org/10.1158/1538-7445.AM2023-1026

Published: 04 April 2023

View articletitled, Abstract 1026: A novel detection system of circulating tumor cells based on size-dependent enrichment with immunofluorescent staining of CK8/18 in advanced non-small cell lung cancer

Journal Articles

Abstract 5238: CLIP1-LTK: A novel druggable gene fusion in non-small cell lung cancer

Hiroki Izumi, Shingo Matsumoto, Jie Liu, Kosuke Tanaka, Shunta Mori, Shogo Kumagai, Takuma Hayashida, Yuji Shibata, Saori Takata, Eriko Tabata, Haruyasu Murakami, Reiko Taki, Satoshi Hara, Tomohiro Sakamoto, Koichi Goto, Susumu S. Kobayashi

Cancer Res (2022) 82 (12_Supplement): 5238.

https://doi.org/10.1158/1538-7445.AM2022-5238

Published: 15 June 2022

View articletitled, Abstract 5238: CLIP1-LTK: A novel druggable gene fusion in non-small cell lung cancer

Journal Articles

Abstract CT106: Phase I/II study of osimertinib in EGFR exon 20 insertion mutations in non-small cell lung cancer patients: AEX20

Eiki Ichihara, Hiroyuki Yasuda, Yuta Takashima, Yoshitaka Zenke, Shinji Takeuchi, Masahiro Morise, Katsuyuki Hotta, Mineyoshi Sato, Shingo Matsumoto, Azusa Tanimoto, Reiko Matsuzawa, Katsuyuki Kiura, Hideki Terai, Shinnosuke Ikemura, Koichi Goto, Kenzo Soejima

Cancer Res (2021) 81 (13_Supplement): CT106.

https://doi.org/10.1158/1538-7445.AM2021-CT106

Published: 01 July 2021

View articletitled, Abstract CT106: Phase I/II study of osimertinib in EGFR exon 20 insertion mutations in non-small cell lung cancer patients: AEX20

Journal Articles

Abstract 4919: Required numbers of biopsy samples and tumor cells for the assessment of PD-L1 expression to predict a response to nivolumab treatment in patients with NSCLC

Jun Sato, Tomoyuki Naito, Hibiki Udagawa, Hidehito Horinouchi, Shuji Murakami, Yasushi Goto, Shintaro Kanda, Yutaka Fujiwara, Noboru Yamamoto, Yuichiro Ohe, Yoshitaka Zenke, Keisuke Kirita, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Noriko Motoi, Genichiro Ishii, Koichi Goto

Cancer Res (2019) 79 (13_Supplement): 4919.

https://doi.org/10.1158/1538-7445.AM2019-4919

Published: 01 July 2019

View articletitled, Abstract 4919: Required numbers of biopsy samples and tumor cells for the assessment of PD-L1 expression to predict a response to nivolumab treatment in patients with NSCLC

Journal Articles

Abstract 4920: A status of re-biopsy for non-small-cell lung cancer patients after first EGFR-TKI failure and incidence of T790M mutation

Tetsuya Sakai, Hibiki Udagawa, Yoshitaka Zenke, Keisuke Kirita, Shigeki Umemura, Shingo Matsumoto, Kiyotaka Yoh, Seiji Niho, Genichiro Ishii, Koichi Goto

Cancer Res (2019) 79 (13_Supplement): 4920.

https://doi.org/10.1158/1538-7445.AM2019-4920

Published: 01 July 2019

View articletitled, Abstract 4920: A status of re-biopsy for non-small-cell lung cancer patients after first EGFR-TKI failure and incidence of T790M mutation

Journal Articles

Metabolic and Physiologic Imaging Biomarkers of the Tumor Microenvironment Predict Treatment Outcome with Radiation or a Hypoxia-Activated Prodrug in Mice

Shingo Matsumoto, Shun Kishimoto, Keita Saito, Yoichi Takakusagi, Jeeva P. Munasinghe, Nallathamby Devasahayam, Charles P. Hart, Robert J. Gillies, James B. Mitchell, Murali C. Krishna

Cancer Res (2018) 78 (14): 3783–3792.

https://doi.org/10.1158/0008-5472.CAN-18-0491

Published: 15 July 2018

View articletitled, Metabolic and Physiologic Imaging Biomarkers of the Tumor Microenvironment Predict Treatment Outcome with Radiation or a Hypoxia-Activated Prodrug in Mice

Includes: Supplementary data

Journal Articles

Abstract 918: A secondary RET mutation allosterically conferring resistance to vandetanib

Takashi Nakaoku, Takashi Kohno, Mitsugu Araki, Seiji Nino, Rakhee Chauhan, Phillip P. Knowles, Katsuya Tsuchihara, Shingo Matsumoto, Yoko Shimada, Sachiyo Mimaki, Genichiro Ishii, Hitoshi Ichikawa, Yasushi Okuno, Kiyotaka Yoh, Neil Q. McDonald, Koichi Goto

Cancer Res (2018) 78 (13_Supplement): 918.

https://doi.org/10.1158/1538-7445.AM2018-918

Published: 01 July 2018

View articletitled, Abstract 918: A secondary RET mutation allosterically conferring resistance to vandetanib

Journal Articles

Metabolic Determinants of Sensitivity to Phosphatidylinositol 3-Kinase Pathway Inhibitor in Small-Cell Lung Carcinoma

Hideki Makinoshima, Shigeki Umemura, Ayako Suzuki, Hiroki Nakanishi, Ami Maruyama, Hibiki Udagawa, Sachiyo Mimaki, Shingo Matsumoto, Seiji Niho, Genichiro Ishii, Masahiro Tsuboi, Atsushi Ochiai, Hiroyasu Esumi, Takehiko Sasaki, Koichi Goto, Katsuya Tsuchihara

Cancer Res (2018) 78 (9): 2179–2190.

https://doi.org/10.1158/0008-5472.CAN-17-2109

Published: 30 April 2018

View articletitled, Metabolic Determinants of Sensitivity to Phosphatidylinositol 3-Kinase Pathway Inhibitor in Small-Cell Lung Carcinoma

Includes: Supplementary data

Journal Articles

Abstract 4111: EGFR wild type allele amplification induces acquired resistance to mutation-specific EGFR tyrosine kinase inhibitors in non-small cell lung cancer cells

Keigo Kobayashi, Shigenari Nukaga, Hiroyuki Yasuda, Keita Masuzawa, Jyunko Hamamoto, Ichiro Kawada, Katsuhiko Naoki, Sachiyo Mimaki, Shingo Matsumoto, Koichi Goto, Katsuya Tsuchihara, Tomoko Betsuyaku, Kenzo Soejima

Cancer Res (2017) 77 (13_Supplement): 4111.

https://doi.org/10.1158/1538-7445.AM2017-4111

Published: 01 July 2017

View articletitled, Abstract 4111: EGFR wild type allele amplification induces acquired resistance to mutation-specific EGFR tyrosine kinase inhibitors in non-small cell lung cancer cells

Journal Articles

Amplification of EGFR Wild-Type Alleles in Non–Small Cell Lung Cancer Cells Confers Acquired Resistance to Mutation-Selective EGFR Tyrosine Kinase Inhibitors

Shigenari Nukaga, Hiroyuki Yasuda, Katsuya Tsuchihara, Junko Hamamoto, Keita Masuzawa, Ichiro Kawada, Katsuhiko Naoki, Shingo Matsumoto, Sachiyo Mimaki, Shinnosuke Ikemura, Koichi Goto, Tomoko Betsuyaku, Kenzo Soejima

Cancer Res (2017) 77 (8): 2078–2089.

https://doi.org/10.1158/0008-5472.CAN-16-2359

Published: 13 April 2017

View articletitled, Amplification of EGFR Wild-Type Alleles in Non–Small Cell Lung Cancer Cells Confers Acquired Resistance to Mutation-Selective EGFR Tyrosine Kinase Inhibitors

Includes: Supplementary data

Journal Articles

Abstract LB-184: Hyperpolarized ¹³C-pyruvate magnetic resonance spectroscopic imaging of prostate cancer tumor xenografts

Bradley T. Scroggins, Masayuki Matsuo, Jeeva P. Munasinghe, Ayla O. White, Carole Sourbier, Shingo Matsumoto, W. Marston Linehan, James B. Mitchell, Murali C. Krishna, Deborah E. Citrin

Cancer Res (2016) 76 (14_Supplement): LB-184.

https://doi.org/10.1158/1538-7445.AM2016-LB-184

Published: 15 July 2016

View articletitled, Abstract LB-184: Hyperpolarized 13C-pyruvate magnetic resonance spectroscopic imaging of prostate cancer tumor xenografts

Journal Articles

Abstract 3361: EGFR signaling regulates aerobic glycolysis in EGFR-mutated lung adenocarcinoma

Hideki Makinoshima, Masahiro Takita, Shingo Matsumoto, Atsushi Yagishita, Satoshi Owada, Hiroyasu Esumi, Katsuya Tsuchihara

Cancer Res (2014) 74 (19_Supplement): 3361.

https://doi.org/10.1158/1538-7445.AM2014-3361

Published: 01 October 2014

View articletitled, Abstract 3361: EGFR signaling regulates aerobic glycolysis in EGFR-mutated lung adenocarcinoma

Journal Articles

Abstract 2208: Detection of somatic mutations and gene amplifications using amplicon sequencing with biopsy samples from patients with advanced gastric cancer

Wataru Okamoto, Takeshi Kuwata, Shingo Matsumoto, Yoichi Naito, Hideaki Takahashi, Kohei Shitara, Yasutoshi Kuboki, Hideaki Bando, Yoko Yamada, Izumi Miki, Takeharu Yamanaka, Atsushi Ohtsu, Atsushi Ochiai, Hiroyasu Esumi, Takayuki Yoshino, Katsuya Tsuchihara

Cancer Res (2014) 74 (19_Supplement): 2208.

https://doi.org/10.1158/1538-7445.AM2014-2208

Published: 01 October 2014

View articletitled, Abstract 2208: Detection of somatic mutations and gene amplifications using amplicon sequencing with biopsy samples from patients with advanced gastric cancer

Journal Articles

Abstract LB-88: A new rapid diagnostic test to identify epidermal growth factor receptor mutations in non-small cell lung cancer.

Hiroki Chikumi, Miyako Takata, Keiji Matsunami, Shingo Matsumoto, Masahiro Kotani, Tomohiro Sakamoto, Hirokazu Touge, Kosuke Yamaguchi, Jun Kurai, Naomi Miyake, Masaki Nakamoto, Tadashi Igishi, Eiji Shimizu

Cancer Res (2013) 73 (8_Supplement): LB-88.

https://doi.org/10.1158/1538-7445.AM2013-LB-88

Published: 15 April 2013

View articletitled, Abstract LB-88: A new rapid diagnostic test to identify epidermal growth factor receptor mutations in non-small cell lung cancer.

Journal Articles

Antiangiogenic Agent Sunitinib Transiently Increases Tumor Oxygenation and Suppresses Cycling Hypoxia

Shingo Matsumoto, Sonny Batra, Keita Saito, Hironobu Yasui, Rajani Choudhuri, Chandramouli Gadisetti, Sankaran Subramanian, Nallathamby Devasahayam, Jeeva P. Munasinghe, James B. Mitchell, Murali C. Krishna

Cancer Res (2011) 71 (20): 6350–6359.

https://doi.org/10.1158/0008-5472.CAN-11-2025

Published: 12 October 2011

View articletitled, Antiangiogenic Agent Sunitinib Transiently Increases Tumor Oxygenation and Suppresses Cycling Hypoxia

Includes: Supplementary data

Journal Articles

Imaging Cycling Tumor Hypoxia

Shingo Matsumoto, Hironobu Yasui, James B. Mitchell, Murali C. Krishna

Cancer Res (2010) 70 (24): 10019–10023.

https://doi.org/10.1158/0008-5472.CAN-10-2821

Published: 14 December 2010

View articletitled, Imaging Cycling Tumor Hypoxia

Journal Articles

Low-Field Magnetic Resonance Imaging to Visualize Chronic and Cycling Hypoxia in Tumor-Bearing Mice

Hironobu Yasui, Shingo Matsumoto, Nallathamby Devasahayam, Jeeva P. Munasinghe, Rajani Choudhuri, Keita Saito, Sankaran Subramanian, James B. Mitchell, Murali C. Krishna

Cancer Res (2010) 70 (16): 6427–6436.

https://doi.org/10.1158/0008-5472.CAN-10-1350

Published: 14 August 2010

View articletitled, Low-Field Magnetic Resonance Imaging to Visualize Chronic and Cycling Hypoxia in Tumor-Bearing Mice

Includes: Multimedia, Supplementary data

Journal Articles

Abstract LB-313: Soluble UL16 binding protein 2 is elevated in the sera of lung cancer patients

Kosuke Yamaguchi, Hiroki Chikumi, Naoki Kinoshita, Asuka Shimizu, Kiyoshi Hashimoto, Jun Kurai, Akira Yamasaki, Masaki Nakamoto, Shingo Matsumoto, Miyako Takata, Tadashi Igishi, Naoto Burioka, Eiji Shimizu

Cancer Res (2010) 70 (8_Supplement): LB-313.

https://doi.org/10.1158/1538-7445.AM10-LB-313

Published: 15 April 2010

View articletitled, Abstract LB-313: Soluble UL16 binding protein 2 is elevated in the sera of lung cancer patients

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 4714: Elucidating mechanisms of acquired resistance to mobocertinib in non-small cell lung cancer harboring EGFR exon 20 insertion mutations

Abstract 7198: Preclinical efficacy of the combination of MEK inhibitor plus KRAS G12D inhibitor for non-small cell lung cancer with KRAS G12D

Abstract 1026: A novel detection system of circulating tumor cells based on size-dependent enrichment with immunofluorescent staining of CK8/18 in advanced non-small cell lung cancer

Abstract 5238: CLIP1-LTK: A novel druggable gene fusion in non-small cell lung cancer

Abstract CT106: Phase I/II study of osimertinib in EGFR exon 20 insertion mutations in non-small cell lung cancer patients: AEX20

Abstract 4919: Required numbers of biopsy samples and tumor cells for the assessment of PD-L1 expression to predict a response to nivolumab treatment in patients with NSCLC

Abstract 4920: A status of re-biopsy for non-small-cell lung cancer patients after first EGFR-TKI failure and incidence of T790M mutation

Metabolic and Physiologic Imaging Biomarkers of the Tumor Microenvironment Predict Treatment Outcome with Radiation or a Hypoxia-Activated Prodrug in Mice

Abstract 918: A secondary RET mutation allosterically conferring resistance to vandetanib

Metabolic Determinants of Sensitivity to Phosphatidylinositol 3-Kinase Pathway Inhibitor in Small-Cell Lung Carcinoma

Abstract 4111: EGFR wild type allele amplification induces acquired resistance to mutation-specific EGFR tyrosine kinase inhibitors in non-small cell lung cancer cells

Amplification of EGFR Wild-Type Alleles in Non–Small Cell Lung Cancer Cells Confers Acquired Resistance to Mutation-Selective EGFR Tyrosine Kinase Inhibitors

Abstract LB-184: Hyperpolarized ¹³C-pyruvate magnetic resonance spectroscopic imaging of prostate cancer tumor xenografts

Abstract 3361: EGFR signaling regulates aerobic glycolysis in EGFR-mutated lung adenocarcinoma

Abstract 2208: Detection of somatic mutations and gene amplifications using amplicon sequencing with biopsy samples from patients with advanced gastric cancer

Abstract LB-88: A new rapid diagnostic test to identify epidermal growth factor receptor mutations in non-small cell lung cancer.

Antiangiogenic Agent Sunitinib Transiently Increases Tumor Oxygenation and Suppresses Cycling Hypoxia

Imaging Cycling Tumor Hypoxia

Low-Field Magnetic Resonance Imaging to Visualize Chronic and Cycling Hypoxia in Tumor-Bearing Mice

Abstract LB-313: Soluble UL16 binding protein 2 is elevated in the sera of lung cancer patients

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only